R.B. Zipursky

425 total citations
10 papers, 266 citations indexed

About

R.B. Zipursky is a scholar working on Psychiatry and Mental health, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, R.B. Zipursky has authored 10 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 2 papers in Pharmacology and 2 papers in Cognitive Neuroscience. Recurrent topics in R.B. Zipursky's work include Schizophrenia research and treatment (5 papers), Epilepsy research and treatment (4 papers) and Electroconvulsive Therapy Studies (3 papers). R.B. Zipursky is often cited by papers focused on Schizophrenia research and treatment (5 papers), Epilepsy research and treatment (4 papers) and Electroconvulsive Therapy Studies (3 papers). R.B. Zipursky collaborates with scholars based in Canada. R.B. Zipursky's co-authors include Claire E. Jones, Shitij Kapur, Gary Remington, Alan E. Wilson, Jean DaSilva, Sylvain Houle, Benjamin Zimmer, Robert W. Baker, Graham Bean and Morton Beiser and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Schizophrenia Research.

In The Last Decade

R.B. Zipursky

10 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R.B. Zipursky Canada	6	198	69	49	36	36	10	266
Neil M. Kurtz United States	11	189 1.0×	71 1.0×	74 1.5×	50 1.4×	33 0.9×	18	393
D. P. Morrison United Kingdom	9	264 1.3×	49 0.7×	38 0.8×	43 1.2×	28 0.8×	13	343
Jenny-Kay Sharpe Australia	6	287 1.4×	47 0.7×	35 0.7×	58 1.6×	66 1.8×	13	350
L. G. Schmidt Germany	10	165 0.8×	93 1.3×	47 1.0×	35 1.0×	16 0.4×	20	370
Robyn McAskill United Kingdom	4	244 1.2×	88 1.3×	82 1.7×	34 0.9×	17 0.5×	6	396
C. A. Gagiano South Africa	6	245 1.2×	57 0.8×	144 2.9×	49 1.4×	42 1.2×	18	384
András Perényi Hungary	10	195 1.0×	48 0.7×	35 0.7×	42 1.2×	30 0.8×	26	290
R. Marcus Germany	9	334 1.7×	32 0.5×	52 1.1×	99 2.8×	40 1.1×	26	387
D Bobon Belgium	10	131 0.7×	35 0.5×	76 1.6×	54 1.5×	41 1.1×	38	300
R.N. Marcus United States	5	396 2.0×	38 0.6×	71 1.4×	59 1.6×	48 1.3×	10	449

Countries citing papers authored by R.B. Zipursky

Since Specialization

Citations

This map shows the geographic impact of R.B. Zipursky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.B. Zipursky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.B. Zipursky more than expected).

Fields of papers citing papers by R.B. Zipursky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.B. Zipursky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.B. Zipursky. The network helps show where R.B. Zipursky may publish in the future.

Co-authorship network of co-authors of R.B. Zipursky

This figure shows the co-authorship network connecting the top 25 collaborators of R.B. Zipursky. A scholar is included among the top collaborators of R.B. Zipursky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.B. Zipursky. R.B. Zipursky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Woods, Scott W., Alan Breier, R.B. Zipursky, et al.. (2003). Olanzapine versus placebo for prodromal symptoms. Schizophrenia Research. 60(1). 306–307. 6 indexed citations

2.

Levinson, Andrea, K. McKenna, Adrienne Einarson, Gideon Koren, & R.B. Zipursky. (2003). Pregnancy outcome in women receiving atypical antipsychotic drugs: A prospective, multicentre, controlled study. Schizophrenia Research. 60(1). 361–361. 5 indexed citations

3.

Jones, Claire E., Shitij Kapur, Gary Remington, & R.B. Zipursky. (2000). 371. Transient d2 dopamine receptor occupancy in low EPS-incidence drugs: PET evidence. Biological Psychiatry. 47(8). S112–S112. 8 indexed citations

4.

Zipursky, R.B., et al.. (1999). Optimal Haloperidol Dosage in First-Episode Psychosis. The Canadian Journal of Psychiatry. 44(2). 164–167. 33 indexed citations

5.

Kapur, Shitij, et al.. (1998). 59. Is amoxapine an atypical antipsychotic? Supportive pet evidence. Biological Psychiatry. 43(8). S18–S18. 1 indexed citations

6.

Kapur, Shitij, et al.. (1998). 60. Pet comparison of 5-HT2 receptor blockade by SSRIs: Nefazodone vs. paroxetine. Biological Psychiatry. 43(8). S18–S19. 1 indexed citations

7.

Kapur, Shitij, Gary Remington, Claire E. Jones, et al.. (1996). High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. American Journal of Psychiatry. 153(7). 948–950. 172 indexed citations

8.

Kapur, Shitij, Gary Remington, Claire E. Jones, et al.. (1996). Relationship between D2 receptor occupancy and plasma haloperidol: A pet study. European Neuropsychopharmacology. 6. 73–73. 1 indexed citations

9.

Kapur, Shitij, Gary Remington, Claire E. Jones, et al.. (1996). What is the lowest effective dose of haloperidol? Evidence from pet studies. Biological Psychiatry. 39(7). 513–513. 5 indexed citations

10.

Zipursky, R.B., Robert W. Baker, & Benjamin Zimmer. (1985). Alprazolam withdrawal delirium unresponsive to diazepam: case report.. PubMed. 46(8). 344–5. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact